Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
van Gelder
T
T
Department of Internal Medicine I, University Hospital Rotterdam, The Netherlands.
Knoop
C J
CJ
Hesse
C J
CJ
Vaessen
L M
LM
Balk
A H
AH
Yzermans
J N
JN
Weimar
W
W
D000911:Antibodies, Monoclonal / Q000097:blood* / Q000627:therapeutic use*; D015703:Antigens, CD / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D011863:Radioimmunoassay; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab